Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Cell signaling pathways and HIV-1 therapeutics
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cell signaling pathways and HIV-1 therapeutics'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Human Immunodeficiency Virus Type 1 (HIV-1)
100%
AIDS/HIV
100%
Cell Signaling Pathways
100%
Host Interaction
100%
Intimate Interaction
100%
Viral
50%
Virus
50%
HIV-associated Neurocognitive Disorders
50%
Cognitive-motor
50%
Anti-HIV Therapeutics
50%
Host Response
50%
Motor Disorders
50%
Pharmaceutical Intervention
50%
Successful Development
50%
Host Cell
50%
Virus Life Cycle
50%
Anti-HIV Therapy
50%
Suppressive Therapy
50%
Thematic Review
50%
Scientific Idea
50%
Complete Solution
50%
Antiviral Inhibitor
50%
Virus-host Interactions
50%
Late Work
50%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Cell Signaling Pathway
100%
HIV/AIDS
40%
Anti-Human Immunodeficiency Virus
40%
Neurologic Disease
20%
Infection
20%
Immune Response
20%
Stereotypic Movement Disorder
20%
Antivirus Agent
20%
HIV Therapy
20%
Virus Cell Interaction
20%
Host Cell
20%
Life Cycle
20%
Immunology and Microbiology
Human Immunodeficiency Virus 1
100%
Signal Transduction
100%
Human Immunodeficiency Virus
100%
HIV/AIDS
40%
Solution and Solubility
20%
Immune Response
20%
Life Cycle
20%
Host Cell
20%
Virus Cell Interaction
20%
Biochemistry, Genetics and Molecular Biology
Signal Transduction
100%
Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
100%
Immune Response
14%
Solution and Solubility
14%
Life Cycle
14%
Virus Cell Interaction
14%
Neuroscience
Cell Signaling
100%
Human Immunodeficiency Virus
100%
Neurological Disorder
11%
Stereotypic Movement Disorder
11%
Antivirals
11%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Anti-Human Immunodeficiency Virus
28%
Neurologic Disease
14%
Infection
14%
Motor Dysfunction
14%
Antivirus Agent
14%
HIV Therapy
14%